A minimum core outcome dataset for the reporting of preclinical chemotherapeutic drug studies: Lessons learned from multiple discordant methodologies in the setting of colorectal cancer-Reference-Cited by-同舟云学术

A minimum core outcome dataset for the reporting of preclinical chemotherapeutic drug studies: Lessons learned from multiple discordant methodologies in the setting of colorectal cancer

Published:2017-04 Issue: Volume:112 Page:80-102
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

West M.A.,Roman A.,Sayan E.,Primrose J.N.,Wedge S.R.,Underwood T.J.,Mirnezami A.H.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference65 articles.

1. Regorafenib inhibits growth, angiogenesis, and metastasis in a highly aggressive, orthotopic colon cancer model;Abou-Elkacem;Cancer Ther. Insights,2013

2. Core information set for oesophageal cancer surgery;Blazeby;Br. J. Surg.,2015

3. Translational medicine synergistic antitumor activity of capecitabine in combination with irinotecan;Cao;Clin. Colorectal Cancer,2005

4. The synergistic effect of rapamycin combined with 5-fluorouracil in BALB/cByJNarl mice bearing CT-26 tumor cells;Chao;Anticancer Res.,2014

5. Evaluation of single agents and combinations of chemotheraputic agents in mouse colon carcinomas;Corbett;Cancer,1977

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of model‐specific histopathology in mouse models of COVID‐19;Journal of Medical Virology;2022-04-13

2. Rational Treatment of Metastatic Colorectal Cancer: A Reverse Tale of Men, Mice, and Culture Dishes;Cancer Discovery;2021-04-05

3. In Vivo Anticancer Activity of a Nontoxic Inert Phenolato Titanium Complex: High Efficacy on Solid Tumors Alone and Combined with Platinum Drugs;ChemMedChem;2018-10-19

4. Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumonia;PLOS ONE;2017-11-20

5. The IGF1R/INSR Inhibitor BI 885578 Selectively Inhibits Growth of IGF2-Overexpressing Colorectal Cancer Tumors and Potentiates the Efficacy of Anti-VEGF Therapy;Molecular Cancer Therapeutics;2017-07-20